Association of IL-1B Gene Polymorphisms with Nasopharyngeal Carcinoma in a Chinese Population

Clinical Oncology

Volumn 20, Issue 3, 2008, Pages 207-211

  Zhu, Yinhua ^a,b   Xu, Yongchun ^c   Wei, Yesheng ^a   Liang, Weibo ^a   Liao, Miao ^a   Zhang, Lin ^a  

^a SICHUAN UNIVERSITY   (China)

^b PLA   (China)

^c Hangzhou Public Security Bureau   (China)

Author keywords

Genetic susceptibility; IL 1 ; nasopharyngeal carcinoma; polymorphism

Indexed keywords

CYTOSINE; INTERLEUKIN 1BETA; THYMINE;

ADULT; ARTICLE; CANCER RISK; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PEPTIDE FRAGMENTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 40649125497     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.01.003     Document Type: Article

References (45)

1. Jeannel D., Bouvier G., and Hubert A. Nasopharyngeal carcinoma: an epidemiological approach to carcinogenesis. Cancer Surv 33 (1999) 125-155
2. Chan A.S., To K.F., Lo K.W., et al. High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res 60 (2000) 5365-5370
3. McDerrmott A.L., Dutt S.N., and Watkinson J.C. The aetiology of nasopharyngeal carcinoma. Clin Otolaryngol 26 (2001) 82-92
4. Xiong W., Zeng Z.Y., Xia J.H., et al. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res 64 (2004) 1972-1974
5. Yu M.C., and Yuan J.M. Epidemiology of nasopharyngeal carcinoma. Cancer Res 12 (2002) 421-430
6. El-Omar E.M., Carrington M., Chow W.H., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 (2000) 398-402
7. Hamajima N., Matsuo K., Saito T., et al. Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection. Jpn J Cancer Res 92 (2001) 383-389
8. Hwang I.R., Kodama T., Kikuchi S., et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin-1 beta production in Helicobacter pylori infection. Gastroenterology 123 (2002) 1793-1803
9. Shanbeh Z., David R., Valentina M., Vidar S., Federico C., and Aage H. Polymorphisms of the interleukin-1β gene are associated with increased risk of non-small cell lung cancer. Int J Cancer 109 (2004) 353-356
10. Liu J.Y., Zhai X.J., Jin G.F., et al. Functional variants in the promoter of interleukin-1β are associated with an increased risk of breast cancer: a case-control analysis in a Chinese population. Int J Cancer 118 (2006) 2554-2558
11. Yasuhito T., Takahisa F., Seiji S., et al. Impact of interleukin-1β genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan. J Infect Dis 187 (2003) 1822-1825
12. Kanemoto K., Kawasaki J., Miyamoto T., Obayashi H., and Nishimura M. Interleukin (IL)-1β, IL-1α, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann Neurol 47 5 (2000) 571-574
13. Shi Y.Y., and He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15 (2005) 97-98
14. Stephens M., Smith M.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68 (2001) 978-989
15. Huang G., Niu T.H., Peng S.J., et al. Association between the interleukin-1β C(-511)T polymorphism and blood pressure in a Chinese hypertensive population. Immunol Lett 91 (2004) 159-162
16. Achyut B.R., Srivastava A., Bhattacharya S., and Mittal B. Genetic association of interleukin-1β (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with type 2 diabetes mellitus in North Indians. Clin Chim Acta 377 (2007) 163-169
17. Roberta Z., Luisella B.C., Catia S., et al. Association between IL-1b-511C/T and IL-1RA (86bp)n repeats polymorphisms and schizophrenia. J Psychiat Res 37 (2003) 457-462
18. Oscar F., German Z., Carlos M., Javier M., and Clara I.G. Interleukin-1 gene cluster polymorphism in Chagas disease in a Colombian case-control study. Hum Immunol 67 (2006) 741-748
19. Tseng L.H., Chen P.J., Lin M.T., et al. Single nucleotide polymorphisms in intron 2 of the human interleukin-1 receptor antagonist (IL-1Ra) gene: further definition of the IL-1 beta and IL-1Ra polymorphisms in North American Caucasians and Taiwanese Chinese. Tissue Antigens 57 (2001) 318-324
20. Mansfield J.C., Holden H., Tarlow J.K., et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 106 (1994) 637-642
21. Lu H., Ouyang W., and Huang C. Inflammation, a key event in cancer development. Mol Cancer Res 4 (2006) 221-233
22. Moss S.F., and Blaser M.J. Mechanisms of disease: inflammation and the origins of cancer. Nat Clin Pract Oncol 2 (2005) 90-97
23. Quirk J.T., and Kupinski J.M. Chronic infection, inflammation, and epithelial ovarian cancer. Med Hypotheses 57 (2001) 426-428
24. Lin W.W., and Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117 (2007) 1175-1183
25. Rollins B.J. Inflammatory chemokines in cancer growth and progression. Eur J Cancer 42 (2006) 760-767
26. Bird S., Zou J., Wang T., Munday B., Cunningham C., and Secombes C.J. Evolution of interleukin-1β. Cytokine Growth Factor Rev 13 (2002) 483-502
27. Castrilli G., Tatone D., Diodoro M.G., Rosini S., Piantelli M., and Musiani P. Interleukin 1alpha and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells. Br J Cancer 75 (1997) 855-859
28. Apte R.N., Douvdevani A., Zoller M., et al. Cytokine-induced tumor immunogenicity: endogenous interleukin-1 alpha expressed by fibrosarcoma cells confers reduced tumorigenicity. Immunol Lett 39 (1993) 45-52
29. Apte R.N., Dvorkin T., Song X., et al. Opposing effects of IL-1 alpha and IL-1 beta on malignancy patterns. Tumor cell-associated IL-1 alpha potentiates anti-tumor immune responses and tumor regression, whereas IL-1 beta potentiates invasiveness. Adv Exp Med Biol 479 (2000) 277-288
30. Glaccum M.B., Stocking K.L., Charrier K., et al. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J Immunol 159 (1997) 3364-3371
31. Wang Y., Kato N., Hoshida Y., et al. Interleukin-1β gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 37 (2003) 65-71
32. Bazrafshani M.R., Hajeer A.H., Ollier W.E., and Thornhill M.H. IL-1B and IL-6 gene polymorphisms encode significant risk for the development of recurrent aphthous stomatitis (RAS). Genes Immunol 3 (2002) 302-305
33. Hulkkonen J., Laippala P., and Hurme M. A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1β plasma levels in healthy individuals. Eur Cytokine Network 11 (2000) 251-255
34. Hulkkonen J., Vilpo J., Vilpo L., Koski T., and Hurme M. Interleukin-1β, interleukin-1 receptor antagonist and interleukin-6 plasma levels and cytokine gene polymorphisms in chronic lymphocytic leukemia: correlation with prognostic parameters. Haematologica 85 (2000) 600-606
35. Santtila S., Savinainen K., and Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1β production in vitro. Scand J Immunol 47 (1998) 195-198
36. Ren W., Zheng H., Li M., et al. A functional single nucleotide polymorphism site detected in nasopharyngeal carcinoma-associated transforming gene Tx. Cancer Genet Cytogenet 157 (2005) 49-52
37. Besma B.H.J., Wijden M., Noureddine B., et al. A polymorphism in FAS gene promoter associated with increased risk of nasopharyngeal carcinoma and correlated with anti-nuclear autoantibodies induction. Cancer Lett 233 (2006) 21-27
38. Danai T., Petcharin S., Anant K., and Takafumi I. Cytochrome P450 2A6 polymorphism in nasopharyngeal carcinoma. Cancer Lett 241 (2006) 135-141
39. Majida J., Noureddine B., Jalel G., Marilys C., Slim B.A., and Lotfi C. Polymorphism of the stress protein HSP70-2 gene is associated with the susceptibility to the nasopharyngeal carcinoma. Cancer Lett 193 (2003) 75-81
40. Danai T., Petcharin S., Anant K., and Takafumi I. The p53 codon 72 polymorphism in Thai nasopharyngeal carcinoma. Cancer Lett 198 (2003) 69-75
41. Nazar-Stewart V., Vaughan T.L., Burt R.D., Chen C., Berwick M., and Swanson G.M. Glutathione S-transferase M1 and susceptibility to nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 8 (1999) 547-551
42. Wei Y.S., Kuang X.H., Zhu Y.H., et al. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma. Tissue Antigens 70 (2007) 12-17
43. Hela B.N., Karim C., Souhir M., Noureddine B., Kaouther S., and Lotfi C. Association of IL-8 (-251)T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma. Human Immunol 68 (2007) 761-769
44. Dinarello C.A. Interleukin-1 and interleukin-1 antagonism. Blood 77 (1991) 1627-1652
45. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 87 (1996) 2095-2147